Ireland· IE-PA-PA1826/002/001
Maxibar 98.45% w/w powder for oral suspension
A bariumsulfat mit suspensions-stabilisator product containing barium sulfate, registered in Ireland by Bracco Imaging spa. The same ATC class is registered in 8 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Bariumsulfat mit suspensions-stabilisator is registered in 8 of 19 countries.
Countries holding a registration under ATC V08BA01 (bariumsulfat mit suspensions-stabilisator), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Bariumsulfat mit suspensions-stabilisator · ATC V08BA01
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Barium sulfate
- Manufacturer
- Bracco Imaging spa
- Country
- Ireland (IE)
- ATC code
- V08BA01
- ATC class
- Bariumsulfat mit Suspensions-Stabilisator
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1826/002/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bariumsulfat mit suspensions-stabilisator in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States¿Baryta muriaticaBoiron
- United KingdomBaritop 100 suspensionSanochemia Diagnostics UK Ltd
- BelgiumBaryta Carbonica Boiron 15CHBoiron
- Japan硫酸バリウムカイゲンファーマ
- NetherlandsBaryta carbonicaHeel Belgium n.v.
- SpainBARIGRAF 555,2 g POLVO PARA SUSPENSION RECTALLaboratorios Ern S.A.
- FinlandBaricolE-Z-EM Nederland B.V.
- NorwayE-z-cat bariumsulfatE-Z-EM Canada Inc.
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Micropaque, Micropaque Ct
- Belgium · Micropaque Scanner, Micropaque Suspensie
- Bulgaria · Дк-Бар
- Czechia · Micropaque, Micropaque Ct
- Germany · Micropaque, Micropaque Ct
- Denmark · Microtrast
- Spain · Barigraf, Barigraf Ad
- France · Micropaque, Micropaque Scanner
- United Kingdom (Northern Ireland) · E-Z-Cat, E-Z-Hd
- Hungary · Micropaque, Micropaque Ct
- Italy · Prontobario Colon, Prontobario Hd
- Luxembourg · Micropaque Scanner, Micropaque Suspension
- Netherlands · E-Z-Cat, E-Z-Hd
- Poland · Barium Sulfuricum Medana
- Portugal · Barigraf Tac, E-Z-Cat
- Romania · Sulfat De Bariu Meduman
- Slovakia · Micropaque, Micropaque Ct
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7f16934-aa3f-4aec-89aa-4ad840256581 GET /v1/drugs/f7f16934-aa3f-4aec-89aa-4ad840256581?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for oral suspension",
"routes": [
"Powder for oral/rectal suspension"
],
"source": "hpra",
"atc_all": [
"V08BA",
"V08BA01"
],
"strength": null,
"pa_number": "PA1826/002/001",
"substances": [
"Barium sulfate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "03/11/1992",
"dispensing_status": "Product subject to Restricted Prescription (C)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about bariumsulfat mit suspensions-stabilisator.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.